BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11005271)

  • 21. Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine.
    Kwekkeboom DJ; de Jong FH; Lamberts SW
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1128-35. PubMed ID: 2542356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study.
    Florio T; Barbieri F; Spaziante R; Zona G; Hofland LJ; van Koetsveld PM; Feelders RA; Stalla GK; Theodoropoulou M; Culler MD; Dong J; Taylor JE; Moreau JP; Saveanu A; Gunz G; Dufour H; Jaquet P
    Endocr Relat Cancer; 2008 Jun; 15(2):583-96. PubMed ID: 18509006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gonadotrophin and alpha subunit secretion by human 'functionless' pituitary adenomas in cell culture: long term effects of luteinizing hormone releasing hormone and thyrotrophin releasing hormone.
    Surmont DW; Winslow CL; Loizou M; White MC; Adams EF; Mashiter K
    Clin Endocrinol (Oxf); 1983 Sep; 19(3):325-36. PubMed ID: 6194923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gonadotrophin and free alpha-subunit secretion in patients with acromegaly and clinically non-functioning pituitary tumors: anterior pituitary function and the effect of thyrotrophin-releasing hormone.
    Damjanović SS; Popović VP; Petakov MS; Nikolic-Durović MM; Doknić MZ; Gligorović MS
    J Endocrinol Invest; 1996 Nov; 19(10):663-9. PubMed ID: 9007697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.
    Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW
    J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gonadotroph adenomas in men produce biologically active follicle-stimulating hormone.
    Galway AB; Hsueh AJ; Daneshdoost L; Zhou MH; Pavlou SN; Snyder PJ
    J Clin Endocrinol Metab; 1990 Oct; 71(4):907-12. PubMed ID: 2119391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ACTH silent adenoma shrinking under cabergoline.
    Petrossians P; Ronci N; Valdés Socin H; Kalife A; Stevenaert A; Bloch B; Tabarin A; Beckers A
    Eur J Endocrinol; 2001 Jan; 144(1):51-7. PubMed ID: 11174837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum alpha-subunit elevation after TRH administration: a valuable test in presurgical diagnosis of gonadotropinoma?
    Gruszka A; Kunert-Radek J; Pawlikowski M
    Endokrynol Pol; 2005; 56(1):14-8. PubMed ID: 16335668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relevance of coexpression of somatostatin and dopamine D2 receptors in pituitary adenomas.
    Saveanu A; Jaquet P; Brue T; Barlier A
    Mol Cell Endocrinol; 2008 May; 286(1-2):206-13. PubMed ID: 18241980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response of luteinizing hormone secreting pituitary adenoma to a long-acting somatostatin analogue.
    Vos P; Croughs RJ; Thijssen JH; van 't Verlaat JW; van Ginkel LA
    Acta Endocrinol (Copenh); 1988 Aug; 118(4):587-90. PubMed ID: 2899940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gonadotropin-producing pituitary adenoma in a man with long-standing primary hypogonadism.
    Nicolis G; Shimshi M; Allen C; Halmi NS; Kourides IA
    J Clin Endocrinol Metab; 1988 Jan; 66(1):237-41. PubMed ID: 2447114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imbalanced follicle-stimulating hormone beta-subunit hormone biosynthesis in human pituitary adenomas.
    Katznelson L; Alexander JM; Bikkal HA; Jameson JL; Hsu DW; Klibanski A
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1343-51. PubMed ID: 1375599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of thyrotropin-releasing hormone test, SMS 201-995, and bromocriptine in the diagnosis and treatment of gonadotropin-secreting pituitary adenomas.
    Blanco C; Lucas T; Alcañiz J; Davila N; Serrano P; Barcelò B; Estrada J
    J Endocrinol Invest; 1994 Feb; 17(2):99-104. PubMed ID: 8006339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Novel pharmacologic therapies in acromegaly].
    Góth M; Hubina E; Kovács L; Szabolcs I
    Orv Hetil; 2002 May; 143(19 Suppl):1057-62. PubMed ID: 12063860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitro.
    Florio T; Thellung S; Corsaro A; Bocca L; Arena S; Pattarozzi A; Villa V; Massa A; Diana F; Schettini D; Barbieri F; Ravetti JL; Spaziante R; Giusti M; Schettini G
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):115-28. PubMed ID: 12807513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gonadotroph cell adenomas of the pituitary.
    Snyder PJ
    Endocr Rev; 1985; 6(4):552-63. PubMed ID: 2416559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antisecretory Effects of Chimeric Somatostatin/Dopamine Receptor Ligands on Gastroenteropancreatic Neuroendocrine Tumors.
    Couvelard A; Pélaprat D; Dokmak S; Sauvanet A; Voisin T; Couvineau A; Ruszniewski P
    Pancreas; 2017; 46(5):631-638. PubMed ID: 28375946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Free alpha-subunit and intact TSH secretion in vitro are closely associated in human somatotroph adenomas.
    Aylwin SJ; King A; Blenke A; Geddes JF; Wood DF; Monson JP; Burrin JM
    Eur J Endocrinol; 1998 Oct; 139(4):378-86. PubMed ID: 9820613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine receptor subtype 2 expression profile in nonfunctioning pituitary adenomas and in vivo response to cabergoline therapy.
    Vieira Neto L; Wildemberg LE; Moraes AB; Colli LM; Kasuki L; Marques NV; Gasparetto EL; de Castro M; Takiya CM; Gadelha MR
    Clin Endocrinol (Oxf); 2015 May; 82(5):739-46. PubMed ID: 25418156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibin and follicle-stimulating hormone levels in gonadotroph adenomas: evidence of a positive correlation with tumour volume in men.
    Lahlou N; Le Nestour E; Chanson P; Seret-Bégué D; Bouchard P; Roger M; Warnet A
    Clin Endocrinol (Oxf); 1993 Mar; 38(3):301-9. PubMed ID: 8458102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.